Ulf Meier-Kriesche
Chief Tech/Sci/R&D Officer chez VELOXIS PHARMACEUTICALS A/S
Profil
Ulf Meier-Kriesche is currently the Chief Scientific Officer at Veloxis Pharmaceuticals A since 2017.
He obtained a doctorate degree from the University of Perugia.
Postes actifs de Ulf Meier-Kriesche
| Sociétés | Poste | Début |
|---|---|---|
| VELOXIS PHARMACEUTICALS A/S | Chief Tech/Sci/R&D Officer | 13/09/2017 |
Formation de Ulf Meier-Kriesche
| University of Perugia | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
